- ListingTrack.io
- Posts
- The Morning SPAC Update (May 13, 2025) ๐
The Morning SPAC Update (May 13, 2025) ๐
The pre-market SPAC recap for ListingTrack Pro users.

Good morning,
You can read this newsletter on your browser in our content library here.
Thanks,
ListingTrack Team
SPAC & De-SPAC Daily Trading (prev. session)
SPAC Gainers & Losers
Ticker | DA Target | Price | Daily % Chg. |
---|---|---|---|
$12.00 | 8.89% | ||
$12.78 | 4.75% | ||
Namib Minerals | $11.25 | 4.17% | |
Kyivstar | $12.60 | 3.36% | |
[LOI 5/13/25: Cartiga] | $12.00 | 2.30% | |
Cyabra | $11.78 | -0.51% | |
AMC Corporation | $11.63 | -0.56% | |
$11.75 | -1.34% | ||
[LOI: Horizon Quantum] | $14.12 | -1.94% | |
Twenty One Capital | $28.06 | -10.95% |
SPAC Volume Leaders
Ticker | DA Target | Volume |
---|---|---|
Twenty One Capital | 2.4M | |
2.2M | ||
1.48M | ||
GrabAGun | 1M | |
Kodiak Robotics | 0.6M | |
Kyivstar | 0.54M |
De-SPAC Gainers & Losers
Ticker | IPO Return | Price | Daily % Chg. |
---|---|---|---|
-87% | $1.31 | 290.93% | |
-89% | $1.07 | 39.94% | |
-99% | $3.13 | 33.76% | |
-83% | $1.74 | 25.18% | |
-99% | $2.15 | 23.56% | |
-83% | $1.74 | -19.26% | |
-63% | $3.70 | -19.91% | |
-99% | $0.30 | -25.07% | |
-99% | $3.82 | -26.25% | |
-99% | $1.58 | -43.17% |
De-SPACs listed from 2019-
De-SPAC Volume Leaders
News & De-SPAC Updates
New Home Co. has agreed to acquire Landsea Homes (Nasdaq: LSEA) in an all-cash deal valuing the homebuilder at roughly $1.2 billion enterprise value. Under the definitive agreement, New Home will launch a tender offer at $11.30 per Landsea Homes shareโa 61% premium to Landseaโs May 12, 2025 closing priceโto purchase all outstanding stock. โ PR
Longevity Health (XAGE) will implement a 1-for-30 reverse stock split ahead of trading on May 14. โ PR
The Deals
1) Horizon Space Acquisition II (HSPT) entered into a definitive agreement to merge with SL Bio, a clinical-stage skin care and cancer recovery therapeutics company. โPR / SF
Target Description (from PR): SL Bio is a biomedical company focused on developing innovative cellular and gene therapies for cancer treatment and regenerative medicine. Leveraging proprietary technologies and strategic partnerships, the company is advancing next-generation immunotherapies and exosome-based products for both medical and consumer applications. SL Bioโs approach combines scientific expertise with a commitment to improving patient outcomes and addressing unmet needs in healthcare. SL Bio also offers ISO-certified, dermatologically tested cow milk-derived exosome-based products and plant extract products for skin and hair care, with commercial distribution in Asia.
SPAC Updates
Extensions
Aquaron (OTC: AQUC) was approved to extend up to May 2026. ~87% of the public SPAC shares were redeemed. Remaining in trust: ~$1.3M / 107,987 shares. โSF
Finnovate (OTC: FNVTF) was approved to extend up to Nov 2025. ~86% of the public SPAC shares were redeemed. Remaining in trust: ~$1.5M / 122,458 shares. โSF
Listings
New Issues: IPOs, New S-1s
IPOs
1) Perimeter Acquisition Corp. I (PMTRU) priced its IPO. โ PR
$210M, 1/2 Warrant
Focus: Defense and national security in the United States or an ally of the US.
UW: Citi
Filings
1) Jena Acquisition Corporation II (JENA) filed for IPO. โ S-1
$200M, 1 R (1/20 sh)
Focus: Fintech, Insurance, Real Estate
UW: Santander
Prominent Mgmt: Bill Foley
Listing Warnings / Transfers:
Cartesian Growth II (RENE โ> RENEF) was delisted from Nasdaq and began trading OTC under the symbols RENEF, REEUF, and REEWF, for its common, units, and warrants, respectively.
Key Filings
Extensions:
S-4 Filings*:
Post-Merger S-1 Filings**:
WeBull (BULL) โ EFFECT
*The latest S-4 filings can be found in the Announced Mergers dataset.
**Includes PIPE resale registrations where applicable โ the latest post-merger S-1 filings can be found in the De-SPAC Screener in the column group โDe-SPAC Profileโ.
Thanks for reading,
The team at ListingTrack (listingtrack.io)
Abbreviations: BC: Business Combination, BCA: Business Combination Agreement, DA: Definitive Agreement, PR: Press Release, SF: Company SEC filing, IP: Investor Presentation
DISCLAIMER: The information provided in this newsletter is for your convenience only and is not intended to be treated as financial, investment, tax, or other advice. ListingTrack, SPAC Track, and the parent, CommonFi, do not make any guarantees, representations, or warranties as to, and shall have no liability for, the timeliness, truthfulness, sequence, quality, completeness, or accuracy of any of the information or data provided in this newsletter or on the ListingTrack website.